{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:19:41Z","timestamp":1761556781247,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.sapharm.2017.05.009","type":"journal-article","created":{"date-parts":[[2017,5,22]],"date-time":"2017-05-22T15:00:13Z","timestamp":1495465213000},"page":"434-440","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The impact of self- and physician-administered cancer treatment on work productivity and healthcare utilization"],"prefix":"10.1016","volume":"14","author":[{"given":"Seth A.","family":"Seabury","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3437-1518","authenticated-orcid":false,"given":"Melissa A.","family":"Frasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"van Eijndhoven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Sison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Zacker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2017","series-title":"Cancer Facts & Figures","author":"American Cancer Society","key":"10.1016\/j.sapharm.2017.05.009_bib1"},{"issue":"30","key":"10.1016\/j.sapharm.2017.05.009_bib2","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1200\/JCO.2013.49.1241","article-title":"Economic burden of cancer survivorship among adults in the United States","volume":"31","author":"Guy","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.sapharm.2017.05.009_bib3","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/pon.1016","article-title":"Absenteeism from work: the experience of employed breast and prostate cancer patients in the months following diagnosis","volume":"15","author":"Bradley","year":"2006","journal-title":"Psychooncology"},{"issue":"2","key":"10.1016\/j.sapharm.2017.05.009_bib4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.critrevonc.2010.01.004","article-title":"Employment and work-related issues in cancer survivors","volume":"77","author":"Mehnert","year":"2011","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"10.1016\/j.sapharm.2017.05.009_bib5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/jnci\/djk001","article-title":"Patient time costs associated with cancer care","volume":"99","author":"Yabroff","year":"2007","journal-title":"J\u00a0Natl Cancer Inst"},{"year":"2016","series-title":"What's New in Breast Cancer Research and Treatment?","author":"American Cancer Society","key":"10.1016\/j.sapharm.2017.05.009_bib6"},{"year":"2016","series-title":"New Directions in Lung Cancer","author":"Lung Cancer Alliance","key":"10.1016\/j.sapharm.2017.05.009_bib7"},{"year":"2017","series-title":"Cancer Statistics","author":"National Cancer Institute","key":"10.1016\/j.sapharm.2017.05.009_bib8"},{"year":"2017","series-title":"Surveillance, Epidemiology, and End Results Program","author":"National Cancer Institute","key":"10.1016\/j.sapharm.2017.05.009_bib9"},{"year":"2017","series-title":"Surveillance, Epidemiology, and End Results Program","author":"National Cancer Institute","key":"10.1016\/j.sapharm.2017.05.009_bib10"},{"key":"10.1016\/j.sapharm.2017.05.009_bib11","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1377\/hlthaff.2012.0174","article-title":"Patients value metastatic cancer therapy more highly than is typically shown through traditional estimates","volume":"31","author":"Seabury","year":"2012","journal-title":"Health Aff (Millwood)"},{"year":"2015","series-title":"Targeted Cancer Therapies","author":"National Cancer Institute","key":"10.1016\/j.sapharm.2017.05.009_bib12"},{"key":"10.1016\/j.sapharm.2017.05.009_bib13","unstructured":"U.S. Food and Drug Administration. Drugs@FDA. https:\/\/www.accessdata.fda.gov\/scripts\/cder\/drugsatfda\/. Accessed 08.01.2015."},{"year":"2015","series-title":"Cancer Therapy Look-up Tables","author":"National Cancer Institute","key":"10.1016\/j.sapharm.2017.05.009_bib14"},{"year":"2015","series-title":"Drugs Approved for Breast Cancer","author":"National Cancer Institute","key":"10.1016\/j.sapharm.2017.05.009_bib15"},{"year":"2015","series-title":"Drugs Approved for Lung Cancer","author":"National Cancer Institute","key":"10.1016\/j.sapharm.2017.05.009_bib16"},{"year":"2015","series-title":"National Drug Code Directory","author":"U.S. Food and Drug Administration","key":"10.1016\/j.sapharm.2017.05.009_bib17"},{"key":"10.1016\/j.sapharm.2017.05.009_bib18","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"issue":"8","key":"10.1016\/j.sapharm.2017.05.009_bib19","first-page":"761","article-title":"Race, socioeconomic status and stage at diagnosis for five common malignancies","volume":"14","author":"Schwartz","year":"2003","journal-title":"Cancer Causes Control"},{"issue":"8","key":"10.1016\/j.sapharm.2017.05.009_bib20","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.mayocp.2015.06.001","article-title":"In support of a patient-driven initiative and petition to lower the high price of cancer drugs","volume":"90","author":"Tefferi","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.sapharm.2017.05.009_bib21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1257\/jep.29.1.139","article-title":"Pricing in the market for anticancer drugs","volume":"29","author":"Howard","year":"2015","journal-title":"J\u00a0Econ Perspect"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741117304928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741117304928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:14:47Z","timestamp":1761556487000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741117304928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S1551741117304928"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2017.05.009","relation":{},"ISSN":["1551-7411"],"issn-type":[{"type":"print","value":"1551-7411"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of self- and physician-administered cancer treatment on work productivity and healthcare utilization","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2017.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}